The use of the TNM classification of tumors—an editorial
✍ Scribed by Jonathan E. Rhoads
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 47 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
One frequent area of uncertainty in assigning proper staging categories is the use of the “X” suffix when assigned to the tumor (T), lymph node (N), or metastasis (M) categories of the TNM classification system. When X is used, patients ordinarily cannot be assigned a stage, e.g., Stage III. The obj
## Abstract A prospective 5‐year clinical trial was conducted by the National Cancer Institute of Canada to assess the TNM classification for breast cancer proposed by the International Union Against Cancer (UICC). The study period was 1960–1964 with a 5‐year follow‐up on all cases. Excluding those
## Abstract The TNM classification is a worldwide benchmark for reporting the extent of malignant disease and is a major prognostic factor in predicting the outcome of patients with cancer. The objectives for cancer staging were defined by the International Union Against Cancer (UICC) TNM Committee